Amanote Research
Register
Sign In
EGFR Kinase Domain Mutations – Functional Impact and Relevance for Lung Cancer Therapy
Oncogene
- United Kingdom
doi 10.1038/sj.onc.1210383
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Genetics
Molecular Biology
Date
March 12, 2007
Authors
D Irmer
J O Funk
A Blaukat
Publisher
Springer Science and Business Media LLC
Related search
Akt Kinase-Interacting Protein1, a Novel Therapeutic Target for Lung Cancer With EGFR-activating and Gatekeeper Mutations
Oncogene
Cancer Research
Genetics
Molecular Biology
EGFR Mutations Status for Non-Small-Cell Lung Cancer Patients
Sveikatos mokslai
Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy
Oncology
Pharmacology
Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations
Cancer Discovery
Oncology
Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Post-Progression Survival After EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
PLoS ONE
Multidisciplinary
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
Targeting Nuclear EGFR: Strategies for Improving Cetuximab Therapy in Lung Cancer
